Significance Of Microrna-183 Family Expression In Cancer Diagnosis: A Meta-Analysis

Hui Xu,Hao Chen,Qiuling Zhang,Xiaoli Zhang,Jian Wang

2016-01-01

Abstract:Cancer is the third major cause of death in the world and it has turned into an enormous threat to human health. MicroRNAs have been considered as novel and noninvasive biomarkers for human cancer detection. The microRNA-183 (miRNA-183, miR-183) family, consisting of miR-96, miR-182 and miR-183, is considered to be associated with various types of human cancer. However, the diagnostic performance of these miRNAs in human cancer detection failed to reach a consensus. Thus, a meta-analysis was carried out to consolidate the existing findings. Several electronic databases were searched systematically for relevant studies and the pooled results were obtained using the random-effects model. Heterogeneity among individual studies was assessed by the Chi-Square test. A total of 1659 cancer patients and 1457 healthy individuals from 17 articles were included in our meta-analysis. The pooled sensitivity and specificity was 0.69 (95% CI: 0.65-0.73) and 0.82 (95% CI: 0.77-0.86), respectively. The area under the curve (AUC) was 0.80 together with a partial AUC of 0.74. Subgroup analysis indicated that ethnicity, cancer, specimen types and quality score might be potential sources of heterogeneity. In conclusion, the relatively high specificity and AUC suggested that miR-183 family members can be adopted to screen human cancer. However, this conclusion should be confirmed by studies with large sample size and confounding factors should also be controlled in the study.